Veru (VERU) Tax Provisions (2012 - 2024)
Veru (VERU) posted quarterly Tax Provisions of $829440.0 for Q3 2024, up 773.44% year-over-year from $94962.1 in Q4 2023, and up 410.67% quarter-over-quarter from $162422.0 in Q2 2024.
Veru (VERU) Tax Provisions (2012 - 2024) Analysis & Trends
Veru (VERU) has reported Tax Provisions for 13 consecutive years, with $829440.0 the latest figure, recorded in Q3 2024.
- In Q3 2024, Tax Provisions rose 773.44% year-over-year to $829440.0; the TTM figure through Sep 2024 stood at -$921369.0 (up 89.21% YoY), while the FY2024 annual figure was $357919.0, up 123.75% from the prior year.
- Tax Provisions rose to $829440.0 in Q3 2024 per VERU's latest filing, from $162422.0 in the prior quarter.
- Across five years, Tax Provisions topped out at $927912.0 in Q3 2022 and bottomed at -$8.1 million in Q4 2022.
- Historically, Tax Provisions has averaged -$899409.5 across 5 years, with a median of -$123164.0 in 2023.
- Annual changes were most pronounced in 2022 — Tax Provisions sank 7893.34% — and 2024, when it jumped 773.44%.
- Veru's Tax Provisions stood at $78302.0 in 2020, then slumped by 230.11% to -$101875.0 in 2021, then tumbled by 7893.34% to -$8.1 million in 2022, then soared by 78.47% to -$1.8 million in 2023, then surged by 147.31% to $829440.0 in 2024.
- Business Quant data shows VERU's Tax Provisions at $829440.0 in Q3 2024, $162422.0 in Q2 2024, and -$160063.0 in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 292.00 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 230.90 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 59.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 15.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 75.45 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 13.31 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -90.33 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 1.90 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Veru | 60.85 Mn | 35.06 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 829,440.00 |
| Jun 30, 2024 | 162,422.00 |
| Mar 31, 2024 | -160,063.00 |
| Dec 31, 2023 | -1.75 Mn |
| Sep 30, 2023 | -123,164.00 |
| Jun 30, 2023 | -202,682.00 |
| Mar 31, 2023 | -66,559.00 |
| Dec 31, 2022 | -8.14 Mn |
| Sep 30, 2022 | 927,912.00 |
| Jun 30, 2022 | -4.63 Mn |
| Mar 31, 2022 | -27,450.00 |
| Dec 31, 2021 | -101,875.00 |
| Sep 30, 2021 | -1.43 Mn |
| Jun 30, 2021 | -1.17 Mn |
| Mar 31, 2021 | 4,993.00 |
| Dec 31, 2020 | 78,302.00 |
| Sep 30, 2020 | -1.41 Mn |
| Jun 30, 2020 | 332,230.00 |
| Mar 31, 2020 | -198,166.00 |
| Dec 31, 2019 | -55,000.00 |